메뉴 건너뛰기




Volumn 87, Issue 7, 2015, Pages 1199-1206

Efficacy of pegylated interferon and ribavirin combination therapy for patients with hepatitis C virus infection after curative resection or ablation for hepatocellular carcinoma-A retrospective multicenter study

Author keywords

Ablation; Curative resection; Hepatitis C; Hepatocellular carcinoma; Peg IFN plus ribavirin combination therapy; Recurrence

Indexed keywords

PEGINTERFERON ALPHA2B; RIBAVIRIN; ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; RECOMBINANT PROTEIN;

EID: 84928743023     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24173     Document Type: Article
Times cited : (10)

References (33)
  • 2
    • 84855833690 scopus 로고    scopus 로고
    • Impact of erythropoietin on sustained virological response to peginterferon and ribavirin therapy for HCV infection: A systematic review and meta-analysis
    • Alavian SM, Tabatabaei SV, Behnava B. 2012. Impact of erythropoietin on sustained virological response to peginterferon and ribavirin therapy for HCV infection: A systematic review and meta-analysis. J Viral Hepat 19:88-93.
    • (2012) J Viral Hepat , vol.19 , pp. 88-93
    • Alavian, S.M.1    Tabatabaei, S.V.2    Behnava, B.3
  • 3
    • 0033646209 scopus 로고    scopus 로고
    • Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan. The liver cancer study group of Japan
    • Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, Makuuchi M, Nakamura Y, Okita K, Yamada R. 2000. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan. The liver cancer study group of Japan. Hepatology 32:1224-1229.
    • (2000) Hepatology , vol.32 , pp. 1224-1229
    • Arii, S.1    Yamaoka, Y.2    Futagawa, S.3    Inoue, K.4    Kobayashi, K.5    Kojiro, M.6    Makuuchi, M.7    Nakamura, Y.8    Okita, K.9    Yamada, R.10
  • 11
    • 84879604456 scopus 로고    scopus 로고
    • Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma
    • Hsu YC, Ho HJ, Wu MS, Lin JT, Wu CY. 2013. Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma. Hepatology 58:150-157.
    • (2013) Hepatology , vol.58 , pp. 150-157
    • Hsu, Y.C.1    Ho, H.J.2    Wu, M.S.3    Lin, J.T.4    Wu, C.Y.5
  • 12
    • 0032955838 scopus 로고    scopus 로고
    • The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States
    • Hu KQ, Tong MJ. 1999. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology 29: 1311-1316.
    • (1999) Hepatology , vol.29 , pp. 1311-1316
    • Hu, K.Q.1    Tong, M.J.2
  • 13
    • 0033854015 scopus 로고    scopus 로고
    • Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer
    • Ikeda K, Arase Y, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, Tsubota A, Chayama K, Murashima N, Kumada H. 2000. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 32:228-232.
    • (2000) Hepatology , vol.32 , pp. 228-232
    • Ikeda, K.1    Arase, Y.2    Saitoh, S.3    Kobayashi, M.4    Suzuki, Y.5    Suzuki, F.6    Tsubota, A.7    Chayama, K.8    Murashima, N.9    Kumada, H.10
  • 14
    • 0345600107 scopus 로고    scopus 로고
    • Recurrence rate and prognosis of patients with hepatocellular carcinoma that developed after elimination of hepatitis C virus RNA by interferon therapy. A closed cohort study including matched control patients
    • Ikeda K, Kobayashi M, Saitoh S, Someya T, Hosaka T, Akuta N, Suzuki F, Tsubota A, Suzuki Y, Arase Y, Kumada H. 2003. Recurrence rate and prognosis of patients with hepatocellular carcinoma that developed after elimination of hepatitis C virus RNA by interferon therapy. A closed cohort study including matched control patients. Oncology 65:204-210.
    • (2003) Oncology , vol.65 , pp. 204-210
    • Ikeda, K.1    Kobayashi, M.2    Saitoh, S.3    Someya, T.4    Hosaka, T.5    Akuta, N.6    Suzuki, F.7    Tsubota, A.8    Suzuki, Y.9    Arase, Y.10    Kumada, H.11
  • 23
    • 77950220516 scopus 로고    scopus 로고
    • Meta-analysis: Interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma
    • Miyake Y, Takaki A, Iwasaki Y, Yamamoto K. 2010. Meta-analysis: Interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma. J Viral Hepat 17:287-292.
    • (2010) J Viral Hepat , vol.17 , pp. 287-292
    • Miyake, Y.1    Takaki, A.2    Iwasaki, Y.3    Yamamoto, K.4
  • 25
    • 0030933395 scopus 로고    scopus 로고
    • Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups
    • Poynard T, Bedossa P, Opolon P. 1997. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:825-832.
    • (1997) Lancet , vol.349 , pp. 825-832
    • Poynard, T.1    Bedossa, P.2    Opolon, P.3
  • 28
    • 77952422635 scopus 로고    scopus 로고
    • Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach
    • Shen YC, Hsu C, Chen LT, Cheng CC, Hu FC, Cheng AL. 2010. Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach. J Hepatol 52:889-894.
    • (2010) J Hepatol , vol.52 , pp. 889-894
    • Shen, Y.C.1    Hsu, C.2    Chen, L.T.3    Cheng, C.C.4    Hu, F.C.5    Cheng, A.L.6
  • 32
    • 53549084881 scopus 로고    scopus 로고
    • Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma
    • Uenishi T, Nishiguchi S, Tanaka S, Yamamoto T, Takemura S, Kubo S. 2008. Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma. J Surg Oncol 98:358-362.
    • (2008) J Surg Oncol , vol.98 , pp. 358-362
    • Uenishi, T.1    Nishiguchi, S.2    Tanaka, S.3    Yamamoto, T.4    Takemura, S.5    Kubo, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.